J. Evensen

1.3k total citations
22 papers, 1.1k citations indexed

About

J. Evensen is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, J. Evensen has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Otorhinolaryngology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in J. Evensen's work include Head and Neck Cancer Studies (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Oral health in cancer treatment (4 papers). J. Evensen is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Lung Cancer Treatments and Mutations (5 papers) and Oral health in cancer treatment (4 papers). J. Evensen collaborates with scholars based in Norway, Denmark and Sweden. J. Evensen's co-authors include Morten Boysen, Magnus Jannert, Eva Hammerlid, Kristin Bjordal, Marianne Ahlner‐Elmqvist, Thomas Westin, Johan Moan, Stein Kaasa, Anders Biörklund and Marianne Sullivan and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and British Journal of Cancer.

In The Last Decade

J. Evensen

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Evensen Norway	10	520	501	399	161	116	22	1.1k
Monica B. Spaulding United States	15	368 0.7×	300 0.6×	523 1.3×	309 1.9×	30 0.3×	34	1.2k
Mark J. Jameson United States	20	176 0.3×	333 0.7×	332 0.8×	523 3.2×	56 0.5×	74	1.2k
Kent Armeson United States	25	391 0.8×	77 0.2×	483 1.2×	230 1.4×	76 0.7×	67	1.5k
Quang Luu United States	23	519 1.0×	843 1.7×	348 0.9×	670 4.2×	65 0.6×	46	1.4k
E. Ehrnrooth United States	17	510 1.0×	312 0.6×	861 2.2×	159 1.0×	44 0.4×	57	1.7k
Frank E. Mott United States	17	521 1.0×	144 0.3×	454 1.1×	158 1.0×	80 0.7×	61	917
Ana Ruiz‐Casado Spain	21	478 0.9×	48 0.1×	847 2.1×	193 1.2×	94 0.8×	88	1.5k
Michael Penniment Australia	13	383 0.7×	103 0.2×	242 0.6×	240 1.5×	44 0.4×	38	822
D K Kelleher Germany	18	250 0.5×	9 0.0×	134 0.3×	145 0.9×	203 1.8×	41	1.1k
Anna Zygogianni Greece	15	161 0.3×	129 0.3×	212 0.5×	151 0.9×	60 0.5×	86	722

Countries citing papers authored by J. Evensen

Since Specialization

Citations

This map shows the geographic impact of J. Evensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Evensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Evensen more than expected).

Fields of papers citing papers by J. Evensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Evensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Evensen. The network helps show where J. Evensen may publish in the future.

Co-authorship network of co-authors of J. Evensen

This figure shows the co-authorship network connecting the top 25 collaborators of J. Evensen. A scholar is included among the top collaborators of J. Evensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Evensen. J. Evensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zätterström, Ulf K., et al.. (2019). Value of patient-reported symptoms in the follow up of patients potentially cured of laryngeal carcinoma. The Journal of Laryngology & Otology. 133(6). 508–514. 7 indexed citations

Eriksen, Jesper Grau, Christian Maare, Jørgen Johansen, et al.. (2015). OC-009: Update of the randomised phase III trial DAHANCA 19: Primary C-RT or RT and zalutumumab for squamous cell carcinomas of head and neck. Radiotherapy and Oncology. 114. 10–10. 7 indexed citations

Eriksen, Jesper Grau, Christian Maare, Jørgen Johansen, et al.. (2014). Evaluation of the EGFR-Inhibitor Zalutumumab Given With Primary Curative (Chemo)radiation Therapy to Patients With Squamous Cell Carcinoma of the Head and Neck: Results of the DAHANCA 19 Randomized Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 88(2). 465–465. 14 indexed citations

Eriksen, Jesper Grau, Christian Maare, Jørgen Johansen, et al.. (2014). OC-0372: DAHANCA19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomas. Radiotherapy and Oncology. 111. S143–S144. 3 indexed citations

Lassen, P., Hanne Primdahl, Jørgen Johansen, et al.. (2012). OC-0149 HPV, SMOKING AND RT-OUTCOME IN ADVANCED OPC TREATED WITHOUT CHEMOTHERAPY – ANALYSIS OF DAHANCA PATIENTS. Radiotherapy and Oncology. 103. S58–S58. 1 indexed citations

Mortensen, Hanna Rahbek, Jens Overgaard, Lena Specht, et al.. (2011). 136 oral RISK FACTORS FOR SWALLOWING DYSFUNCTION AFTER RADIOTHERAPY IN THE DAHANCA 6 & 7 RANDOMIZED TRIAL. Radiotherapy and Oncology. 99. S50–S50.

Overgaard, Jens, Camilla Molich Hoff, Harald S. Hansen, et al.. (2009). Randomized study of darbepoetin alfa as modifier of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): Final outcome of the DAHANCA 10 trial. Journal of Clinical Oncology. 27(15_suppl). 6007–6007. 29 indexed citations

Overgaard, Anne Julie, Camilla Molich Hoff, Hanne Sand Hansen, et al.. (2007). 6LB Randomized study of the importance of Novel Erythropoiesis Stimulating Protein (Aranesp®) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) – the Danish Head and Neck Cancer Group DAHANCA 10 randomized trial. European Journal of Cancer Supplements. 5(6). 7–7. 82 indexed citations

Grau, Cai, HH Hansen, Lena Specht, et al.. (2003). Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 57(2). S154–S154. 8 indexed citations

10.

Overgaard, Jens, Hanne Sand Hansen, Marie Overgaard, et al.. (2003). 1065 A randomized trial with 1485 patients evaluating the importance of accelerated versus conventional fractionated radiotherapy in squamous cell carcinoma of the head and neck. Final results of the DAHANCA 6&7 study. European Journal of Cancer Supplements. 1(5). S318–S318. 1 indexed citations

11.

Støre, G., J. Evensen, & Tore A. Larheim. (2001). Osteoradionecrosis of the mandible. Comparison of the effects of external beam irradiation and brachytherapy. Dentomaxillofacial Radiology. 30(2). 114–119. 6 indexed citations

12.

Hammerlid, Eva, Kristin Bjordal, Marianne Ahlner‐Elmqvist, et al.. (2001). A Prospective Study of Quality of Life in Head and Neck Cancer Patients. Part I: At Diagnosis. The Laryngoscope. 111(4). 669–680. 157 indexed citations

13.

Bjordal, Kristin, Marianne Ahlner‐Elmqvist, Eva Hammerlid, et al.. (2001). A Prospective Study of Quality of Life in Head and Neck Cancer Patients. Part II: Longitudinal Data. The Laryngoscope. 111(8). 1440–1452. 266 indexed citations

14.

Hammerlid, Eva, Marianne Ahlner‐Elmqvist, Kristin Bjordal, et al.. (1999). A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. British Journal of Cancer. 80(5-6). 766–774. 198 indexed citations

15.

Vermund, Halvor, Morten Boysen, J. Evensen, et al.. (1998). Recurrence after Different Primary Treatment for Cancer of the Supraglottic Larynx. Acta Oncologica. 37(2). 167–173. 8 indexed citations

16.

Overgaard, Jens, Hanne Sand Hansen, Marie Overgaard, et al.. (1997). 106 Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week-report from the Dahanca 7 trial. International Journal of Radiation Oncology*Biology*Physics. 39(2). 188–188. 36 indexed citations

17.

Vermund, Halvor, Morten Boysen, J. Evensen, et al.. (1990). Primary Irradiation, Surgery or Combined Therapy in Squamous Cell Carcinoma of the Larynx: A comparison of treatment results from two centers. Acta Oncologica. 29(4). 489–503. 19 indexed citations

18.

Rimington, C., et al.. (1989). Preparation and Photosensitizing Properties of Hematoporphyrin Ethers. Free Radical Research Communications. 7(3-6). 139–142. 4 indexed citations

19.

Moan, Johan, Qian Peng, J. Evensen, et al.. (1987). PHOTOSENSITIZING EFFICIENCIES, TUMOR‐ and CELLULAR UPTAKE OF DIFFERENT PHOTOSENSITIZING DRUGS RELEVANT FOR PHOTODYNAMIC THERAPY OF CANCER. Photochemistry and Photobiology. 46(5). 713–721. 174 indexed citations

20.

Evensen, J. & Johan Moan. (1982). Photodynamic action and chromosomal damage: A comparison of haematoporphyrin derivative (HpD) and light with X-irradiation. British Journal of Cancer. 45(3). 456–465. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact